Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure

overall (A) and specific (B) RESULTS Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure Eva Venegas1, Tomas Lucas2, Monica Marazuela3, Guillem Cuatrecasas4, Maria Angeles Galvez5, Enrique Romero6, Francisco Morales7, Susan M Webb*8, Betina Biaggeti9, Juan Jose Diaz10, Jose Antonio Mato11, Ricardo Vilchez12, Ignacio Bernabeu13, Miguel Paja*14, Antonio Pico*15, Manuel Puig Domingo16, Alfonso Soto1 on behalf of the ACROCOMB study group